ROBERT C MERTON
CIK 1201888 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.18M
Companies
2
Total Filings
18
Lifetime Open-Market Net
$971.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASIC | Director | 48,038 | $24.59 | $1.18M | $800.0K | 2 | 2026-06-15 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 13,636 | — | — | $171.0K | 16 | 2018-05-24 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-28 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +5,953 | $60 | EDGAR |
| 2013-05-13 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Exer (M) | +12,500 | $44.9K | EDGAR |
| 2012-05-29 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +7,328 | $73 | EDGAR |
| 2011-05-31 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +18,750 | $188 | EDGAR |
| 2010-05-27 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +18,750 | $188 | EDGAR |
| 2009-05-28 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | +12,500 | $125 | EDGAR |
| 2008-05-22 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-23 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.